Evidence map›Paper›PMID 41324775›Full record

ReviewLa Radiologia medica2026

[

Riccardo Gerosa, Fabrizia Gelardi, Paola Tiberio, Flavia Jacobs, Chiara Benvenuti, Mariangela Gaudio, Jacopo Canzian, Benedetta Tinterri, Alberto Zambelli, Armando Santoro and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Riccardo GerosaHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Fabrizia GelardiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy.
Paola TiberioHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Flavia JacobsHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Chiara BenvenutiHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Mariangela GaudioHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Jacopo CanzianHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Benedetta TinterriHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Alberto ZambelliHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Armando SantoroHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.
Lidija Antunovic *IRCCS San Raffaele Hospital, Milan, Italy.
Rita De SanctisHumanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy. rdesanctis@asst-pg23.it.ORCID http://orcid.org/0000-0003-3202-1933

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decades, neoadjuvant systemic treatment (NAT) has been increasingly adopted in early-stage breast cancer (BC), highlighting the need for a more accurate assessment of treatment response. Imaging tools such as [

Indexed as

Breast NeoplasmsFluorodeoxyglucose F18Neoadjuvant TherapyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsFemaleHumansSensitivity and SpecificityTreatment OutcomeFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDG PET/CT(De)-escalation strategiesEarly breast cancerNeoadjuvant therapyPathological complete response (pCR)

Identifiers

PMID41324775
PMCPMC13102866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.